These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31911174)

  • 1. Host-guest fabrication of dual-responsive hyaluronic acid/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy.
    Lu J; Luo B; Chen Z; Yuan Y; Kuang Y; Wan L; Yao L; Chen X; Jiang B; Liu J; Li C
    Int J Biol Macromol; 2020 Mar; 146():363-373. PubMed ID: 31911174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-responsive smart cyclodextrin-gated mesoporous silica nanoparticles with ligand-receptor engagement for anti-cancer treatment.
    Wu Y; Xu Z; Sun W; Yang Y; Jin H; Qiu L; Chen J; Chen J
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109831. PubMed ID: 31349481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property.
    Liao T; Liu C; Ren J; Chen H; Kuang Y; Jiang B; Chen J; Sun Z; Li C
    Int J Biol Macromol; 2021 Jul; 183():2017-2029. PubMed ID: 34097958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH/H
    Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
    Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepwise-acid-active organic/inorganic hybrid drug delivery system for cancer therapy.
    Chen H; Chen Z; Kuang Y; Li S; Zhang M; Liu J; Sun Z; Jiang B; Chen X; Li C
    Colloids Surf B Biointerfaces; 2018 Jul; 167():407-414. PubMed ID: 29704741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
    Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y
    Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH/GSH-Dual-Sensitive Hollow Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Cancer Therapy.
    Chen Z; Wan L; Yuan Y; Kuang Y; Xu X; Liao T; Liu J; Xu ZQ; Jiang B; Li C
    ACS Biomater Sci Eng; 2020 Jun; 6(6):3375-3387. PubMed ID: 33463161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.
    Naz S; Wang M; Han Y; Hu B; Teng L; Zhou J; Zhang H; Chen J
    Int J Nanomedicine; 2019; 14():2533-2542. PubMed ID: 31114189
    [No Abstract]   [Full Text] [Related]  

  • 15. An Adjustable pH-Responsive Drug Delivery System Based on Self-Assembly Polypeptide-Modified Mesoporous Silica.
    Yang C; Shi Z; Feng C; Li R; Luo S; Li X; Ruan L
    Macromol Biosci; 2020 Jun; 20(6):e2000034. PubMed ID: 32329202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging.
    Ma Y; Zhou H; Hu F; Pei Z; Xu Y; Shuai Q
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S900-S910. PubMed ID: 30371105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-responsive controlled release of mesoporous silica nanoparticles capped with Schiff base copolymer gatekeepers: Experiment and molecular dynamics simulation.
    Peng S; Yuan X; Lin W; Cai C; Zhang L
    Colloids Surf B Biointerfaces; 2019 Apr; 176():394-403. PubMed ID: 30660963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
    Li J; Du X; Zheng N; Xu L; Xu J; Li S
    Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of multifunctional mesoporous SiO
    Wu Y; Sun Z; Song J; Mo L; Wang X; Liu H; Ma Y
    Nanotechnology; 2022 Nov; 34(5):. PubMed ID: 36317264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.